Canada Markets closed

Amyris, Inc. (AMRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.39+0.34 (+3.33%)
At close: 4:00PM EST

Amyris, Inc.

5885 Hollis Street
Suite 100
EmeryVille, CA 94608
United States
510 450 0761

Sector(s)Basic Materials
IndustrySpecialty Chemicals
Full Time Employees561

Key Executives

NameTitlePayExercisedYear Born
Mr. John G. MeloPres, CEO & Director1.15MN/A1966
Mr. Eduardo AlvarezChief Operating Officer665.19kN/A1964
Ms. Kathleen ValiasekChief Bus. Officer588.08kN/A1964
Mr. Hermanus KieftenbeldChief Financial OfficerN/AN/A1966
Mr. Anthony HughesChief Accounting OfficerN/AN/A1965
Mr. Peter DeNardoSr. Director of Investor Relations & Corp. CommunicationsN/AN/AN/A
Ms. Nicole KelseyGen. Counsel & Sec.N/AN/A1966
Ms. Beth Baker BannermanSr. VP of Corp. Communications & EngagementN/AN/AN/A
Ms. Christine OforiChief People OfficerN/AN/AN/A
Mr. Charles KraftSr. VP of Global Manufacturing & Process Devel.N/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Amyris, Inc., a biotechnology company, develops technology that creates microbial strains to produce artemisinic acid, a precursor of artemisinin, an anti-malarial drug. The company's technology platform enables to engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into large volume, high-value ingredients. It applies technology platform to engineer, manufacture, and sell products for the clean health and beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

Corporate Governance

Amyris, Inc.’s ISS Governance QualityScore as of January 22, 2021 is 10. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.